Header Logo

Connection

LI-YUAN YU-LEE to Dasatinib

Back to Details
This is a "connection" page, showing publications LI-YUAN YU-LEE has written about Dasatinib.
LI-YUAN YU-LEE
Connection Strength
0.019
Dasatinib
  1. Src family kinase/abl inhibitor dasatinib suppresses proliferation and enhances differentiation of osteoblasts. Oncogene. 2010 Jun 03; 29(22):3196-207.
    View in: PubMed
    Score: 0.019
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.